Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2015
Reply to the letter to the editor 'Journey to a faraway land' by Alkan et al
A D Hartkopf, S Y Brucker, F-A Taran
Geburtshilfe Und Frauenheilkunde
|
November 7, 2014
Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials
A D Hartkopf, T Fehm, M Wallwiener, et al.
Geburtshilfe Und Frauenheilkunde
|
April 25, 2017
Circulating Tumor Cells in Early-Stage Breast Cancer
A D Hartkopf, M Banys, N Krawczyk, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 2014
Trastuzumab Administration in Patients with Metastatic Breast Cancer - Experience of a Large University Breast Center
A D Hartkopf, M H Brendel, M Wallwiener, et al.
Journal of Cancer Research and Clinical Oncology
|
June 29, 2016
Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?
C W Wallwiener, A D Hartkopf, E Grabe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2015
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse
A D Hartkopf, M Wallwiener, T N Fehm, et al.
Gynecologic Oncology
|
May 17, 2013
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
A D Hartkopf, S Bossow, J Lampe, et al.
Archives of Gynecology and Obstetrics
|
February 4, 2026
Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area
A Englisch, K Eissler, D Dannehl, et al.
Journal of Translational Medicine
|
July 24, 2025
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer
S M Greiner, J Mauermann, M S Lutz, et al.
Archives of Gynecology and Obstetrics
|
April 21, 2026
The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study
K Eissler, T Engler, D Dannehl, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2015
Reply to the letter to the editor 'Journey to a faraway land' by Alkan et al
A D Hartkopf, S Y Brucker, F-A Taran
Geburtshilfe Und Frauenheilkunde
|
November 7, 2014
Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials
A D Hartkopf, T Fehm, M Wallwiener, et al.
Geburtshilfe Und Frauenheilkunde
|
April 25, 2017
Circulating Tumor Cells in Early-Stage Breast Cancer
A D Hartkopf, M Banys, N Krawczyk, et al.
Geburtshilfe Und Frauenheilkunde
|
July 1, 2014
Trastuzumab Administration in Patients with Metastatic Breast Cancer - Experience of a Large University Breast Center
A D Hartkopf, M H Brendel, M Wallwiener, et al.
Journal of Cancer Research and Clinical Oncology
|
June 29, 2016
Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?
C W Wallwiener, A D Hartkopf, E Grabe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2015
Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse
A D Hartkopf, M Wallwiener, T N Fehm, et al.
Gynecologic Oncology
|
May 17, 2013
Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
A D Hartkopf, S Bossow, J Lampe, et al.
Archives of Gynecology and Obstetrics
|
February 4, 2026
Impact of chemotherapy dose capping on treatment intensity and survival in early breast cancer patients with high body surface area
A Englisch, K Eissler, D Dannehl, et al.
Journal of Translational Medicine
|
July 24, 2025
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer
S M Greiner, J Mauermann, M S Lutz, et al.
Archives of Gynecology and Obstetrics
|
April 21, 2026
The adverse prognostic impact of reduced chemotherapy dose intensity appears attenuated in early breast cancer patients with treatment-relevant neutropenia: a retrospective cohort study
K Eissler, T Engler, D Dannehl, et al.
Page
of 2